Irinotecan Jazeera 20 mg/ml Concentrate for Solution for Infusion 2ml Vial

Irinotecan Jazeera 20 mg/ml concentrate for solution for infusion is a vital medication used in the treatment of certain types of cancer.

This product is specifically formulated as a concentrate that requires dilution before intravenous administration.

It is manufactured by Jazeera Pharmaceutical Industries, a trusted name in the pharmaceutical sector, ensuring high quality and efficacy.

Benefits of Use

Irinotecan Jazeera is primarily used as an antineoplastic agent (chemotherapy drug) for:

• Treatment of metastatic colorectal cancer, either as monotherapy or in combination with other chemotherapy agents.
• Management of other solid tumors, as determined by a healthcare professional.
• It works by inhibiting topoisomerase I, an enzyme crucial for DNA replication, thereby preventing cancer cell growth and proliferation.

How to Use

1. Irinotecan Jazeera is a prescription-only medication and must be administered by a qualified healthcare professional.
2. The concentrate must be diluted in 5% Dextrose Injection or 0.9% Sodium Chloride Injection prior to intravenous administration.
3. The diluted solution should be infused over a period of 30 to 90 minutes.
4. Dosage and administration schedule will be determined by the treating physician based on the patient's condition, body surface area, and other factors.
5. Follow all instructions provided by your physician and pharmacist carefully.

Caution & Warnings

• This medication should only be administered under the supervision of a physician experienced in the use of anticancer agents.
• Irinotecan can cause severe adverse reactions, including myelosuppression (decreased bone marrow activity leading to low blood cell counts) and severe diarrhea, which can be life-threatening.
• Patients should be monitored closely for signs of neutropenic fever, infection, and dehydration.
• Avoid use in pregnant or breastfeeding women due to potential harm to the fetus or infant.
• Inform your doctor about all other medications you are taking, including over-the-counter drugs, supplements, and herbal products, as drug interactions can occur.
• Do not self-administer.

Ingredients

Active Ingredient: Irinotecan hydrochloride trihydrate equivalent to 20 mg/ml Irinotecan.

Excipients: Typically include sorbitol, lactic acid, and water for injection (specific excipients may vary by manufacturer, refer to the package leaflet for full details).

Product Details

• Form: Concentrate for solution for infusion
• Strength: 20 mg/ml
• Volume: 2ml per vial
• Manufacturer: Jazeera Pharmaceutical Industries
• Storage: Store below 30°C. Protect from light. Do not refrigerate or freeze.
• Legal Status: Prescription Only Medicine (POM)